News
Novo Nordisk A/S (NYSE:NVO) is one of the stocks Jim Cramer talked about. A caller asked if investors should take advantage ...
The U.S. is engaged in various activities from international deportation agreements to tackling AI-induced job fears. Notable developments include Google's $30 million settlement over YouTube's child ...
Rob Abbott, CEO, ISPOR, highlights how uniting regulators, payers, and academic leaders worldwide can accelerate access to innovative treatments and strengthen evidence-based healthcare.
Ten stocks took a beating on Wednesday, mimicking a mostly pessimistic broader market, as investors repositioned portfolios ...
The Global Mass Spectrometry Market size valued at approximately USD 6.9 billion in 2024, is projected to reach USD 10.38 billion by 2030, growing at ...
Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical ...
Cell culture is a foundational technology widely used across fields such as pharmaceutical production, regenerative medicine, food ...
Cell culture is a foundational technology widely used across fields such as pharmaceutical production, regenerative medicine, ...
In the third part of his Pharma Commerce video interview, Mark Lee, MarqVision’s founder and CEO, describes how AI-driven ...
The life sciences industry needs a shot of adrenaline. An aging population and a rise in chronic diseases are fueling the ...
Headquartered in Massachusetts, Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is a commercial-stage oncology company engaged in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results